Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07859813 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Trial to Evaluate the Efficacy and Safety of ARO-INHBE in Adults With Metabolic Dysfunction-Associated Steatohepatitis

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is designed to evaluate the safety and efficacy of ARO-INHBE in adults with suspected metabolic dysfunction-associated steatohepatitis (MASH).
Trial Details
NCT Number NCT07859813
Lead Sponsor Arrowhead Pharmaceuticals
Conditions
(from sponsor)		 Metabolic Dysfunction-Associated Steatohepatitis
Enrollment 252 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov